• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

CinCor Pharma, Inc. - Common Stock (NQ:CINC)

N/A UNCHANGED
Last Price Updated: 4:00 PM EST, Feb 23, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about CinCor Pharma, Inc. - Common Stock

< Previous 1 2 3 4 Next >
News headline image
$18 Million Bet On This Biotechnology Stock? 4 Stocks Insiders Are Buying ↗
August 18, 2022
Although US stocks closed lower on Wednesday following the release of Fed minutes, there were a few notable insider trades. 
Via Benzinga
News headline image
Insiders Buy Around $70M Of 4 Stocks: Six Flags Entertainment, MGM Resorts And More ↗
August 16, 2022
Although US stocks closed higher on Monday, there were a few notable insider trades. 
Via Benzinga
News headline image
Biotech Daily: Regulatory Setback For CorMedix, Mersana & GSK In Cancer Pact, BARDA Funding For Opioid Overdose Hopeful ↗
August 09, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours: 
Via Benzinga
News headline image
Recap of Monday's Biotech Catalysts - End Of the Day Summary ↗
August 08, 2022
 
Via Benzinga
News headline image
CinCor Pharma Shares Trade Higher After Positive Data From Hypertension Drug ↗
August 08, 2022
 
Via Benzinga
News headline image
Why Karuna Therapeutics Jumped Around 72%; Here Are 96 Biggest Movers From Yesterday ↗
August 09, 2022
Gainers Helbiz, Inc. (NASDAQ: HLBZ) jumped 114.6% to close at $1.61 on Monday after climbing over 27% on Friday. 
Via Benzinga
News headline image
Nasdaq Turns Lower; Crude Oil Rises Over 1% ↗
August 08, 2022
U.S. stocks pared gains toward the end of trading, with the S&P 500 and the Nasdaq turning lower on Monday. 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Monday's Intraday Session ↗
August 08, 2022
  
Via Benzinga
News headline image
Dow Jumps Over 150 Points; Karuna Therapeutics Shares Spike Higher ↗
August 08, 2022
U.S. stocks traded higher this morning, following the release of strong jobs data on Friday. 
Via Benzinga
News headline image
Why U.S. Stocks Are Trading Higher; Tyson Foods Earnings Miss Views ↗
August 08, 2022
U.S. stocks traded higher this morning, following the release of strong jobs data on Friday. 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Monday's Pre-Market Session ↗
August 08, 2022
  
Via Benzinga
News headline image
Why CinCor Pharma Is Trading Higher By 63%, Here Are 79 Stocks Moving In Monday's Mid-Day Session ↗
August 08, 2022
Gainers Bonso Electronics International Inc. (NASDAQ: BNSO) shares jumped 132% to $11.12 after jumping around 46% on Friday. The company recently said it expects unaudited comprehensive loss of $1.6... 
Via Benzinga
News headline image
Recap Of Tuesday's Biotech Catalysts - End of The Day Summary ↗
July 26, 2022
 
Via Benzinga
News headline image
Twitter Shares Surge Around 8%, Here's 66 Biggest Movers From Yesterday ↗
July 14, 2022
Gainers Qurate Retail, Inc. (NASDAQ: QRTEB) shares climbed 71.1% to close at $5.20. Qurate Retail will host a conference call to discuss Q2 results on Friday, August 5th. 
Via Benzinga
News headline image
Dow Down Triple Digits As Inflation Pressures Ramp Up ↗
July 13, 2022
The Dow Jones Industrial Average is down over 200 points midday, while the Nasdaq Composite and S&P 500 Index struggle for direction following today's highly-anticipated inflation data. 
Via Talk Markets
News headline image
Twitter, Delta Air Lines And 45 Stocks Moving In Wednesday's Mid-Day Session ↗
July 13, 2022
Gainers Qurate Retail, Inc. (NASDAQ: QRTEB) shares jumped 122.4% to $6.76. Qurate Retail will host a conference call to discuss Q2 results on Friday, August 5th. 
Via Benzinga
News headline image
7 No-Brainer Biotech Stocks to Add to Your Buy List ↗
June 09, 2022
With the broader markets grumbling, investors should consider biotech stocks to buy for their permanently relevant profile. 
Via InvestorPlace
News headline image
63 Biggest Movers From Yesterday ↗
June 17, 2022
Gainers Advent Technologies Holdings, Inc. (NYSE: ADN) shares surged 244% to close at $3.99 on Thursday after the company announced it received notification of euro 782.1 million of funding from the... 
Via Benzinga
News headline image
CinCor Pharma Begins Patient Dosing In Midstage Hypertension, Kidney Disease Study ↗
June 01, 2022
CinCor Pharma (NASDAQ: CINC) has dosed first patient in the figHTN-CKD Phase 2 clinical study of its drug candidate Baxdrostat (CIN-107) for the treatment of patients with uncontrolled hypertension and... 
Via Benzinga
News headline image
60 Biggest Movers From Yesterday ↗
April 26, 2022
Gainers Nkarta, Inc. (NASDAQ: NKTX) shares climbed 140.9% to close at $18.72 on Monday after the company announced Phase 1 data from independent dose finding studies of its two... 
Via Benzinga
News headline image
Opening Day: AN2 Therapeutics Rises In Public Debut After Upsized IPO ↗
March 26, 2022
Shares of AN2 Therapeutics rose over 15% in its trading debut on Friday following an upsized initial public offering. This was only the second initial public offering this month, as the IPO market... 
Via Talk Markets
News headline image
75 Biggest Movers From Yesterday ↗
March 22, 2022
Gainers NeuroSense Therapeutics Ltd. (NASDAQ: NRSN) shares jumped 299.4% to close at $6.23 on Monday as the company received clearance from the FDA to initiate a pharmacokinetic... 
Via Benzinga
News headline image
Earnings Scheduled For March 22, 2022 ↗
March 22, 2022
Companies Reporting Before The Bell • GDS Holdings (NASDAQ:GDS) is projected to report quarterly loss at $0.18 per share on revenue of $338.69 million. • HUYA (... 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Monday's After-Market Session ↗
March 21, 2022
Gainers Allarity Therapeutics (NASDAQ:ALLR) stock rose 25.3% to $2.84 during Monday's after-market session. The market value of their outstanding shares is at $22.9 million. 
Via Benzinga
News headline image
46 Stocks Moving In Monday's Mid-Day Session ↗
March 21, 2022
Gainers NeuroSense Therapeutics Ltd. (NASDAQ: NRSN) climbed 369% to $7.32 as the company received clearance from the FDA to initiate a pharmacokinetic study of PrimeC in... 
Via Benzinga
News headline image
CinCor Pharma Q4 2021 Earnings Conference Call On March 22, 2022 At 08:30 AM ET ↗
March 17, 2022
CinCor Pharma (NASDAQ:CINC) will host a conference call at 08:30 AM ET on March 22, 2022, to discuss Q4 2021 earnings results. How to Attend CinCor Pharma (CINC) Conference Call... 
Via Benzinga
News headline image
67 Biggest Movers From Yesterday ↗
March 01, 2022
Gainers Mullen Automotive, Inc. (NASDAQ: MULN) climbed 145.6% to close at $1.69 on Monday after the company reported progress on solid-state polymer battery pack... 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Monday's Intraday Session ↗
February 28, 2022
Gainers IntriCon (NASDAQ:IIN) shares increased by 37.4% to $23.93 during Monday's regular session. The current volume of 1.0 million shares is 3684.0% of IntriCon'... 
Via Benzinga
News headline image
42 Stocks Moving In Monday's Mid-Day Session ↗
February 28, 2022
Gainers Mullen Automotive, Inc. (NASDAQ: MULN) jumped 74.4% to $1.20 after the company reported progress on solid-state polymer battery pack development. Renewable Energy Group... 
Via Benzinga
News headline image
The Week Ahead In Biotech (Jan 31-Feb 5): Merck, Bristol-Myers Squibb, Lilly & Novartis Headline Large-Cap Biopharma Earnings News ↗
January 31, 2022
The broader market weakness pervaded into the biotech sector in the week ending Jan. 28, sending stocks lower. 
Via Benzinga
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap